Genetic diversity of VAR2CSA ID1-DBL2Xb in worldwide Plasmodium falciparum populations: Impact on vaccine design for placental malaria
Bita Bordbar, Nicaise Tuikue Ndam, Emmanuelle Renard, Sayeh Jafari-Guemouri, Livingstone Tavul, Charlie Jennison, Sedami Gnidehou, Rachida Tahar, Dionicia Gamboa, Jorge Bendezu, Didier Menard, Alyssa E Barry, Philippe Deloron, Audrey Sabbagh
Infection, Genetics and Evolution | ELSEVIER SCIENCE BV | Published : 2014
Awarded by "Investissements d'avenir'' - Laboratory of excellence GREx
Awarded by European 7th Framework Programme
Awarded by French National Agency of Research
Awarded by National Health and Medical Research Council of Australia Project
We are grateful to all subjects who participated in the study. We also thank Jerome Clain for helpful discussions. UMR216 is supported by the ''Investissements d'avenir'' funded Laboratory of excellence GREx. Samples from Benin were collected in the context of the STOPPAM (Strategies TO Prevent Pregnancy Associated Malaria) project. STOPPAM is a Small & Medium Scale Collaborative Project supported by the European 7th Framework Programme, contract number: 200889. Samples from Senegal were collected with the funding from the French National Agency of Research (Grant # ANR-05-MIME-009-01). The Papua New Guinea (PNG) samples were collected by N. Senn, I. Mueller and colleagues at the PNG Institute of Medical Research with support from a grant from the Bill and Melinda Gates Foundation. Molecular work on PNG samples was supported by the National Health and Medical Research Council of Australia Project Grant No. 1005653 and the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS.